We are live on ! Find out more
Amundi

Amundi Portfolio holdings

AUM $445B Turnover 8.9%
1-Year Est. Return 36.51%
 

Amundi is a French asset manager formed in 2010 when Crédit Agricole and Société Générale combined their fund management businesses. Its roots go back to 1996, when Crédit Agricole created its asset management subsidiary. It runs mutual funds, index funds and ETFs, and Crédit Agricole remains its majority shareholder. Amundi has grown by acquisition, announcing the purchase of Pioneer Investments, the asset management arm of Italian bank UniCredit, in 2016 and of Lyxor, a business bought from Société Générale, in 2021. In 2025 Amundi combined its US business with Victory Capital and became a strategic shareholder in that firm.

This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+36.51%
3 Year Est. Return
+142.38%
5 Year Est. Return
+174.77%
10 Year Est. Return
+683.06%
AUM
$27.6B
AUM Growth
+$1.08B
Cap. Flow
-$1.1B
Cap. Flow %
-3.98%
Top 10 Hldgs %
16.67%
Holding
682
New
59
Increased
200
Reduced
268
Closed
71
Avg Time Held
1.1 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
0.9 years

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$140M
2
MNK
Mallinckrodt
MNK
+$119M
3
KO icon
Coca-Cola
KO
+$87.2M
4
WFC icon
Wells Fargo
WFC
+$64.2M
5
PARA icon
Paramount Global Class B
PARA
+$61.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.78%
2 Financials 14.97%
3 Technology 12.55%
4 Industrials 11.71%
5 Consumer Discretionary 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$4.98T
$759M 2.75%
27,511,540
+1,396,320
+5% +$38M
2013 Q2
6 quarters
MSFT icon
2
Microsoft
MSFT
$3.6T
$757M 2.75%
16,286,645
+339,867
+2% +$16M
2013 Q2
6 quarters
CVS icon
3
CVS Health
CVS
$103B
$529M 1.92%
5,496,034
+123,435
+2% +$10.9M
2013 Q2
6 quarters
GOOG icon
4
Alphabet (Google) Class C
GOOG
$3.25T
$429M 1.56%
16,244,300
+1,039,160
+7% +$28M
2013 Q2
6 quarters
DIS icon
5
Walt Disney
DIS
$202B
$383M 1.39%
4,070,247
-242,189
-6% -$21.8M
2013 Q2
6 quarters
CELG
6
DELISTED
Celgene
CELG
$378M 1.37%
3,376,570
+296,196
+10% +$31.2M
2013 Q2
6 quarters
EMC icon
7
DELISTED
EMC
EMC
$368M 1.33%
12,362,086
+519,254
+4% +$15.1M
2013 Q2
6 quarters
ROST icon
8
Ross Stores
ROST
$68.2B
$349M 1.27%
7,411,976
-175,356
-2% -$7.4M
2013 Q2
6 quarters
RTX icon
9
RTX
RTX
$257B
$325M 1.18%
2,821,972
-216,896
-7% -$23.5M
2013 Q2
6 quarters
WFC icon
10
Wells Fargo
WFC
$236B
$316M 1.15%
5,772,154
+1,212,883
+27% +$64.2M
2013 Q2
6 quarters
GILD icon
11
Gilead Sciences
GILD
$206B
$300M 1.09%
3,180,990
-355,075
-10% -$36.7M
2013 Q2
6 quarters
JNJ icon
12
Johnson & Johnson
JNJ
$651B
$285M 1.03%
2,722,369
-1,480,313
-35% -$156M
2013 Q2
6 quarters
PNC icon
13
PNC Financial Services
PNC
$84.7B
$274M 0.99%
3,003,503
-456,387
-13% -$39.6M
2013 Q2
6 quarters
AAL icon
14
American Airlines Group
AAL
$7.89B
$271M 0.98%
5,053,840
-688,061
-12% -$29.6M
2014 Q3
1 quarter
BAC icon
15
Bank of America
BAC
$325B
$268M 0.97%
14,970,279
-20,313
-0.1% -$348K
2013 Q2
6 quarters
HD icon
16
Home Depot
HD
$338B
$260M 0.94%
2,477,455
+88,784
+4% +$8.62M
2013 Q2
6 quarters
MMM icon
17
3M
MMM
$91.8B
$250M 0.91%
1,521,789
-66,829
-4% -$10.3M
2013 Q2
6 quarters
TMO icon
18
Thermo Fisher Scientific
TMO
$248B
$246M 0.89%
1,965,136
-20,395
-1% -$2.48M
2013 Q2
6 quarters
HSY icon
19
Hershey
HSY
$35.3B
$246M 0.89%
2,368,523
-119,930
-5% -$11.7M
2013 Q2
6 quarters
LO
20
DELISTED
Lorillard
LO
$235M 0.85%
3,729,183
+155,941
+4% +$9.6M
2013 Q2
6 quarters
ESRX
21
DELISTED
Express Scripts Holding
ESRX
$226M 0.82%
2,667,725
-37,082
-1% -$2.9M
2013 Q2
6 quarters
AET
22
DELISTED
Aetna Inc
AET
$219M 0.79%
2,463,870
+2,520
+0.1% +$211K
2013 Q2
6 quarters
CAH icon
23
Cardinal Health
CAH
$63.1B
$213M 0.77%
2,639,786
+203,338
+8% +$16.1M
2013 Q2
6 quarters
MS icon
24
Morgan Stanley
MS
$259B
$206M 0.75%
5,316,312
-309,825
-6% -$11M
2013 Q2
6 quarters
COV
25
DELISTED
Covidien
COV
$205M 0.75%
2,008,046
+237,153
+13% +$22.7M
2013 Q2
6 quarters

Similar funds

Amundi's Q4 2014 Portfolio in Review

As of Q4 2014, Amundi held 682 positions worth $27.6B, up 4.1% from $26.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Amundi withdrew a net $1.1B in Q4 2014, closing 71 positions and reducing 268 holdings. Its most notable exit was Kodiak Oil & Gas, an estimated $92.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

Against the trend, Amundi opened a new position in Exelon worth $47M.

  • Amundi's largest Q4 2014 buy was Exelon: 1,266,860 shares worth $47M.
  • Amundi added most to ExxonMobil in Q4 2014, an estimated $140M increase.
  • Amundi's biggest Q4 2014 reduction was Johnson & Johnson, cutting an estimated $156M.
  • Amundi fully exited Kodiak Oil & Gas in Q4 2014, selling an estimated $92.4M.
  • Amundi's ten largest holdings make up 17% of its $27.6B portfolio in Q4 2014.
  • Amundi opened 59 new positions and closed 71 in Q4 2014.
  • Amundi's portfolio value rose 4.1% quarter-over-quarter to $27.6B.

Based on Amundi's 13F filing for Q4 2014, filed 9 Feb 2015.